Article info
PDFMovement disorders
Review
Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes
- Correspondence to Dr Nin Bajaj, Department of Clinical Neurology, National Parkinson's Foundation of Excellence, Nottingham University Hospitals NHS Trust and University of Nottingham, Queen's Medical Centre Campus, Derby Road, Nottingham, NG7 2UH, UK; Nin.Bajaj{at}nuh.nhs.uk
Citation
Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes
Publication history
- Received October 26, 2012
- Revised February 11, 2013
- Accepted February 18, 2013
- First published March 13, 2013.
Online issue publication
June 13, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/